<div id=toc></div>

# Table of Contents

- [q-bio.GN](#q-bio.GN) [Total: 2]
- [q-bio.QM](#q-bio.QM) [Total: 7]
- [q-bio.MN](#q-bio.MN) [Total: 1]
- [cs.LG](#cs.LG) [Total: 3]
- [cs.DC](#cs.DC) [Total: 1]
- [stat.ML](#stat.ML) [Total: 1]


<div id='q-bio.GN'></div>

# q-bio.GN [[Back]](#toc)

### [1] [Challenges in structural variant calling in low-complexity regions](https://arxiv.org/abs/2509.23057)
*Qian Qin,Heng Li*

Main category: q-bio.GN

TL;DR: 该研究发现基因组中仅占1.2%的低复杂度区域(LCRs)包含了69.1%的结构变异(SVs)，且长读长SV检测工具在这些区域的错误率高达77.3-91.3%。


<details>
  <summary>Details</summary>
Motivation: 结构变异(SVs)是长度≥50bp的基因组差异，即使在长序列读取下也难以检测，且这些困难的来源尚未得到充分量化。

Method: 识别了GRCh38基因组中的35.4Mb低复杂度区域(LCRs)，并分析了HG002样本中SV在这些区域的分布情况，评估了不同长读长SV检测工具在LCRs中的错误率。

Result: LCRs虽然只覆盖基因组的1.2%，但包含了69.1%的可靠SVs；不同SV检测工具在LCRs中的错误SV调用比例达77.3-91.3%，且错误率随LCR长度增加而上升。

Conclusion: SVs在LCRs中富集且难以准确检测，需要对这类变异进行特殊关注和谨慎分析。

Abstract: Background: Structural variants (SVs) are genomic differences $\ge$50 bp in
length. They remain challenging to detect even with long sequence reads, and
the sources of these difficulties are not well quantified.
  Results: We identified 35.4 Mb of low-complexity regions (LCRs) in GRCh38.
Although these regions cover only 1.2% of the genome, they contain 69.1% of
confident SVs in sample HG002. Across long-read SV callers, 77.3-91.3% of
erroneous SV calls occur within LCRs, with error rates increasing with LCR
length.
  Conclusion: SVs are enriched and difficult to call in LCRs. Special care need
to be taken for calling and analyzing these variants.

</details>


### [2] [Contrastive Learning Enhances Language Model Based Cell Embeddings for Low-Sample Single Cell Transcriptomics](https://arxiv.org/abs/2509.23543)
*Luxuan Zhang,Douglas Jiang,Qinglong Wang,Haoqi Sun,Feng Tian*

Main category: q-bio.GN

TL;DR: 提出了一个将单细胞RNA测序与大型语言模型结合的计算框架，通过将高表达基因映射到NCBI基因描述并使用语言模型生成嵌入，改进了视网膜神经节细胞的亚型分类并揭示了选择性神经元易损性的通路。


<details>
  <summary>Details</summary>
Motivation: 大型语言模型在生物医学数据分析中的应用仍处于起步阶段，特别是在单细胞转录组分析中，罕见亚型对扩展法则提出了挑战。需要开发能够利用先验知识增强生物分析的方法。

Method: 将单细胞RNA测序数据中每个细胞的高表达基因映射到NCBI基因描述，然后使用text-embedding-ada-002、BioBERT和SciBERT等模型生成知识引导的基因嵌入。

Result: 应用于视网膜神经节细胞分析，该策略改进了亚型分类，突出了生物学显著特征，并揭示了与青光眼相关神经退行性变中选择性神经元易损性相关的通路。

Conclusion: 该方法展示了在数据有限条件下，LLM衍生的嵌入如何增强生物分析，并为单细胞生物学中未来基础模型的发展奠定了基础。

Abstract: Large language models (LLMs) have shown strong ability in generating rich
representations across domains such as natural language processing and
generation, computer vision, and multimodal learning. However, their
application in biomedical data analysis remains nascent. Single-cell
transcriptomic profiling is essential for dissecting cell subtype diversity in
development and disease, but rare subtypes pose challenges for scaling laws. We
present a computational framework that integrates single-cell RNA sequencing
(scRNA-seq) with LLMs to derive knowledge-informed gene embeddings. Highly
expressed genes for each cell are mapped to NCBI Gene descriptions and embedded
using models such as text-embedding-ada-002, BioBERT, and SciBERT. Applied to
retinal ganglion cells (RGCs), which differ in vulnerability to
glaucoma-related neurodegeneration, this strategy improves subtype
classification, highlights biologically significant features, and reveals
pathways underlying selective neuronal vulnerability. More broadly, it
illustrates how LLM-derived embeddings can augment biological analysis under
data-limited conditions and lay the groundwork for future foundation models in
single-cell biology.

</details>


<div id='q-bio.QM'></div>

# q-bio.QM [[Back]](#toc)

### [3] [Patient-specific Biomolecular Instruction Tuning](https://arxiv.org/abs/2509.22853)
*Irsyad Adam,Zekai Chen,David Laub,Shaun Porwal,Arda Pekis,Kevin Brown*

Main category: q-bio.QM

TL;DR: 提出了CPTAC-PROTSTRUCT数据集和KRONOS框架，用于基于蛋白质组学的癌症精准医疗，通过多模态语言模型理解患者特异性分子特征。


<details>
  <summary>Details</summary>
Motivation: 蛋白质组学数据对理解疾病表型至关重要，但目前缺乏用于临床解释的指令调优数据集和适合分子数据异质性的语言建模架构。

Method: 创建了包含40万+开放示例的CPTAC-PROTSTRUCT数据集，并提出KRONOS图-LLM框架，利用分子相互作用拓扑学习患者特异性图表示。

Result: KRONOS在分子分类、时间轨迹建模和肿瘤分期预测等临床任务中表现出竞争力。

Conclusion: 该方法使LLM能够理解患者层面的发病机制，通过更准确的诊断、预后和治疗分层推进精准医疗。

Abstract: Proteomics data is essential to pathogenic understanding of a disease
phenotype. In cancer, analysis of molecular signatures enables precision
medicine through the identification of biological processes that drive
individualized tumor progression, therapeutic resistance, and clinical
heterogeneity. Recent advances in multimodal large language models (LLMs) have
shown remarkable capacity to integrate and reason across heterogeneous data
modalities. However, performing multi-modal language modeling for molecular
understanding of patient-specific proteomics remains a significant challenge
due to two barriers: (1) the lack of instruction-tuning datasets that enable
clinical interpretation from proteomics data, and (2) the absence of language
modeling architectures designed to capture the rich heterogeneity of molecular
data. In this work, we introduce CPTAC-PROTSTRUCT, the first instruction tuning
dataset for molecular understanding of oncology, comprising over 400k
open-ended examples derived from individualized proteomic profiles curated from
the largest national proteomics cancer study (CPTAC). Additionally, we propose
KRONOS (Knowledge Representation of patient Omics Networks in Oncology via
Structured tuning), a novel graph-LLM framework that leverages molecular
interaction topology with proteomics to learn patient-specific graph
representations for enhanced clinical reasoning. We show that KRONOS achieves
competitive performance across benchmark clinical tasks, including molecular
classification, temporal trajectory modeling, and tumor stage prediction from
proteomics data. Ultimately, this approach empowers LLMs to understand
patient-level pathogenesis, advancing precision medicine through more accurate
diagnosis, prognosis, and treatment stratification.

</details>


### [4] [Beyond the Clinic: A Large-Scale Evaluation of Augmenting EHR with Wearable Data for Diverse Health Prediction](https://arxiv.org/abs/2509.22920)
*Will Ke Wang,Rui Yang,Chao Pang,Karthik Natarajan,Nan Liu,Daniel McDuff,David Slotwiner,Fei Wang,Xuhai Orson Xu*

Main category: q-bio.QM

TL;DR: 该研究提出了一个多模态健康结果预测框架，整合电子健康记录（EHR）和可穿戴设备数据，证明可穿戴数据能显著提升健康结果预测性能。


<details>
  <summary>Details</summary>
Motivation: EHR主要记录临床事件，但缺乏日常行为和生活方式信息；可穿戴设备能提供连续的活动、心率和睡眠等补充信号，但之前缺乏系统评估可穿戴数据对EHR预测的增益效果。

Method: 开发可扩展的多模态健康结果预测框架，整合EHR和可穿戴数据流，比较不同编码方法（传统特征工程和基础模型嵌入）在All of Us项目数据上的表现。

Result: 在10个临床结果中，可穿戴数据整合持续改善模型性能：重度抑郁症AUROC平均提升5.8%，高血压提升10.7%，糖尿病提升12.2%；平均所有结果AUROC提升8.9%。

Conclusion: 这是首次大规模评估可穿戴-EHR融合的研究，证明可穿戴信号能补充EHR，实现更全面、个性化的健康结果预测，并为优化可穿戴数据基础模型及其与EHR的整合指明了未来方向。

Abstract: Electronic health records (EHRs) provide a powerful basis for predicting the
onset of health outcomes. Yet EHRs primarily capture in-clinic events and miss
aspects of daily behavior and lifestyle containing rich health information.
Consumer wearables, by contrast, continuously measure activity, heart rate, and
sleep, and more, offering complementary signals that can fill this gap. Despite
this potential, there has been little systematic evaluation of the benefit that
wearable data can bring to health outcome prediction on top of EHRs. In this
study, we present an extensible framework for multimodal health outcome
prediction that integrates EHR and wearable data streams. Using data from the
All of Us Program, we systematically compared the combination of different
encoding methods on EHR and wearable data, including the traditional feature
engineering approach, as well as foundation model embeddings. Across ten
clinical outcomes, wearable integration consistently improved model performance
relative to EHR-only baselines, e.g., average delta AUROC +5.8% for major
depressive disorder, +10.7% for hypertension, and +12.2% for diabetes. On
average across all ten outcomes, fusing EHRs with wearable features shows 8.9%
improvement in AUROC. To our knowledge, this is the first large-scale
evaluation of wearable-EHR fusion, underscoring the utility of wearable-derived
signals in complementing EHRs and enabling more holistic, personalized health
outcome predictions. Meanwhile, our analysis elucidates future directions for
optimizing foundation models for wearable data and its integration with EHR
data.

</details>


### [5] [Twin Peaks: Dual-Head Architecture for Structure-Free Prediction of Protein-Protein Binding Affinity and Mutation Effects](https://arxiv.org/abs/2509.22950)
*Supantha Dey,Ratul Chowdhury*

Main category: q-bio.QM

TL;DR: 提出了一种新颖的双头深度学习架构，仅使用蛋白质序列信息即可同时预测结合亲和力(ΔG)和突变诱导的亲和力变化(ΔΔG)。


<details>
  <summary>Details</summary>
Motivation: 现有方法需要蛋白质结构数据和结合界面信息，这限制了在未知结构或难以结晶蛋白质（如病毒蛋白和内在无序蛋白）上的应用。

Method: 采用基于transformer的编码器和新颖的交叉注意力机制，处理成对蛋白质序列，无需结构信息。使用ESM3表示嵌入输入序列，通过可学习的切片窗口嵌入层管理变长序列，共享表示网络分别输出ΔG和ΔΔG预测。

Result: 模型在ΔΔG验证中达到Pearson相关系数0.485，同时保持强力的ΔG预测能力(Pearson: 0.638)。

Conclusion: 该方法消除了对蛋白质结构数据的依赖，为众多未知结构或难以结晶的蛋白质提供了关键优势。

Abstract: We present a novel dual-head deep learning architecture for protein-protein
interaction modeling that enables simultaneous prediction of binding affinity
($\Delta G$) and mutation-induced affinity changes ($\Delta\Delta G$) using
only protein sequence information. Our approach offers a significant
advancement over existing methods by employing specialized prediction heads
that operate on a shared representation network, allowing direct and optimized
prediction of both values. To ensure robust generalization, we integrated
complementary datasets from SKEMPI v2 and PDBbind with a rigorous protein
domain-based splitting strategy that prevents information leakage between
training and validation sets. Our architecture combines transformer-based
encoders with a novel cross-attention mechanism that processes paired protein
sequences directly, without requiring any structural information. The network
embeds input sequences using ESM3 representations, then employs a learnable
sliced window embedding layer to manage variable-length sequences efficiently.
A multi-layer transformer encoder with bidirectional self-attention captures
intra-protein patterns, while cross-attention layers enable explicit modeling
of interactions between protein pairs. This shared representation network feeds
into separate $\Delta G$ and $\Delta\Delta G$ prediction heads, allowing
task-specific optimization while leveraging common features. The model achieves
$\Delta\Delta G$ validation of Pearson correlation at 0.485, while maintaining
strong $\Delta G$ predictions (Pearson: 0.638). While existing approaches
require protein structure data and binding interface information, our model
eliminates these constraints. This provides a critical advantage for the
numerous proteins with unknown structures or those challenging to crystallize,
such as viral and intrinsically disordered proteins.

</details>


### [6] [Uncertainty Quantification of Bacterial Microcompartment Permeability](https://arxiv.org/abs/2509.23445)
*Andre Archer,Brett J. Palmero,Charlotte Abrahamson,Carolyn E. Mills,Nolan W. Kennedy,Danielle Tullman-Ercek,Niall M. Mangan*

Main category: q-bio.QM

TL;DR: 本文构建了沙门氏菌微区室(MCPs)的数学模型，发现存在两种不同的动力学机制，揭示了MCPs通过选择性渗透性来隔离有毒中间产物丙醛的机制。


<details>
  <summary>Details</summary>
Motivation: 研究沙门氏菌在1,2-丙二醇暴露下表达的微区室(MCPs)如何通过选择性渗透性来限制有毒中间产物丙醛的暴露，并提高代谢通量。

Method: 构建了纯化MCPs的质量作用数学模型，将参数校准到测量的代谢物浓度，并将质量作用动力学参数约束到先前估计的米氏参数。

Result: 识别出两种不同的拟合结果，推断MCP对1,2-丙二醇和丙醛的渗透性应分别大于10^-6和10^-8 m/s。辅酶A(CoA)渗透性存在双峰分布，要么小于10^-8.8 m/s，要么大于10^-7.3 m/s。

Conclusion: 结果支持MCPs通过选择性扩散隔离有毒丙醛的理论，双峰性源于CoA渗透性和抑制率的双峰分布。需要6-24小时之间的额外数据点或酶抑制率表征来减少不确定性。

Abstract: $\textit{Salmonella}$ expresses bacterial microcompartments (MCPs) upon
1,2-propanediol exposure. MCPs are nanoscale protein-bound shells that encase
enzymes for the cofactor-dependent 1,2-propanediol metabolism. They are
hypothesized to limit exposure to the toxic intermediate, propionaldehyde,
decrease cofactor involvement in competing reactions, and enhance flux. We
construct a mass-action mathematical model of purified MCPs and calibrate
parameters to measured metabolite concentrations. We constrain mass-action
kinetic parameters to previously estimated Michaelis-Menten parameters. We
identified two distinct fits with different dynamics in the pathway product,
propionate, but similar goodness of fit. Across fits, we inferred that the MCP
1,2-propanediol and propionaldehyde permeability should be greater than
$10^{-6}$ and $10^{-8}$ m/s, respectively. Our results identify parameter
ranges consistent with prevailing theories that MCPs impose preferential
diffusion to 1,2-propanediol over propionaldehyde, and sequester toxic
propionaldehyde away from the cell cytosol. The bimodality of the posterior
distribution arises from bimodality in the estimated coenzyme-A (CoA)
permeability and inhibition rates. The MCP permeability to CoA was inferred to
be either less than $10^{-8.8}$ m/s or greater than $10^{-7.3}$ m/s. In a high
CoA permeability environment with low rates of CoA inhibition, enzymes produced
metabolites by recycling (NAD+)/(NADH). In a low CoA permeability environment
with high rates of CoA inhibition, enzymes required external NAD+/H to produce
metabolites. Dynamics are consistent with prevailing hypotheses about MCP
function to sequester toxic propionaldehyde, and additional collection of data
points between 6 and 24 hours or characterization of enzyme inhibition rates
could further reduce uncertainty and provide better permeability estimates.

</details>


### [7] [13CFLUX -- Third-generation high-performance engine for isotopically (non)stationary 13C metabolic flux analysis](https://arxiv.org/abs/2509.23847)
*Anton Stratmann,Martin Beyß,Johann F. Jadebeck,Wolfgang Wiechert,Katharina Nöh*

Main category: q-bio.QM

TL;DR: 13CFLUX(v3)是一个第三代13C代谢通量分析模拟平台，结合高性能C++引擎和Python接口，提供显著的性能提升，支持多种标记策略和分析平台。


<details>
  <summary>Details</summary>
Motivation: 随着13C-MFA数据复杂性和方法多样性的增加，对模拟软件提出了更高要求，需要高性能且灵活的解决方案。

Method: 开发了结合高性能C++引擎和Python接口的模拟平台，支持同位素稳态和非稳态分析工作流程，具备多实验集成、多示踪剂研究和高级统计推断功能。

Result: 软件实现了跨工作流程的显著性能提升，保持灵活性以适应多样化的标记策略和分析平台，开源可用性便于集成和扩展。

Conclusion: 13CFLUX为现代通量组学研究提供了一个稳健且可扩展的框架，支持多实验集成、多示踪剂研究和贝叶斯分析等高级功能。

Abstract: 13C-based metabolic flux analysis (13C-MFA) is a cornerstone of quantitative
systems biology, yet its increasing data complexity and methodological
diversity place high demands on simulation software. We introduce 13CFLUX(v3),
a third-generation simulation platform that combines a high-performance C++
engine with a convenient Python interface. The software delivers substantial
performance gains across isotopically stationary and nonstationary analysis
workflows, while remaining flexible to accommodate diverse labeling strategies
and analytical platforms. Its open-source availability facilitates seamless
integration into computational ecosystems and community-driven extension. By
supporting multi-experiment integration, multi-tracer studies, and advanced
statistical inference such as Bayesian analysis, 13CFLUX provides a robust and
extensible framework for modern fluxomics research.

</details>


### [8] [LAMP-PRo: Label-aware Attention for Multi-label Prediction of DNA- and RNA-binding Proteins using Protein Language Models](https://arxiv.org/abs/2509.24262)
*Nimisha Ghosh,Dheeran Sankaran,Rahul Balakrishnan Adhi,Sharath S,Amrut Anand*

Main category: q-bio.QM

TL;DR: LAMP-PRo是一个基于预训练蛋白质语言模型、注意力机制和多标签学习的新框架，用于准确区分DNA结合蛋白(DBP)、RNA结合蛋白(RBP)以及同时结合两者的蛋白(DRBP)，解决了现有方法交叉预测错误高的问题。


<details>
  <summary>Details</summary>
Motivation: 由于DNA和RNA结合蛋白高度相似，现有方法难以准确区分它们，导致高交叉预测错误。同时识别同时结合DNA和RNA的蛋白质(DRBP)也是一个挑战。

Method: 使用预训练蛋白质语言模型ESM-2嵌入蛋白质序列，结合CNN、多头自注意力机制和标签感知注意力，并引入跨标签注意力机制来捕获DNA和RNA结合蛋白之间的依赖关系，最后通过线性层和sigmoid函数进行多标签预测。

Result: 与现有方法相比，LAMP-PRo表现出持续有竞争力的性能，并提供可视化展示模型可解释性，突出显示序列中对预测标签最相关的部分。

Conclusion: LAMP-PRo框架能有效解决DNA和RNA结合蛋白的区分问题，通过创新的注意力机制提高了DRBP的预测准确性，并提供了模型可解释性分析。

Abstract: Identifying DNA- (DBPs) and RNA-binding proteins (RBPs) is crucial for the
understanding of cell function, molecular interactions as well as regulatory
functions. Owing to their high similarity, most of the existing approaches face
challenges in differentiating between DBPs and RBPs leading to high
cross-prediction errors. Moreover, identifying proteins which bind to both DNA
and RNA (DRBPs) is also quite a challenging task. In this regard, we propose a
novel framework viz. LAMP-PRo which is based on pre-trained protein language
model (PLM), attention mechanisms and multi-label learning to mitigate these
issues. First, pre-trained PLM such ESM-2 is used for embedding the protein
sequences followed by convolutional neural network (CNN). Subsequently
multi-head self-attention mechanism is applied for the contextual information
while label-aware attention is used to compute class-specific representations
by attending to the sequence in a way that is tailored to each label (DBP, RBP
and non-NABP) in a multi-label setup. We have also included a novel cross-label
attention mechanism to explicitly capture dependencies between DNA- and
RNA-binding proteins, enabling more accurate prediction of DRBP. Finally, a
linear layer followed by a sigmoid function are used for the final prediction.
Extensive experiments are carried out to compare LAMP-PRo with the existing
methods wherein the proposed model shows consistent competent performance.
Furthermore, we also provide visualization to showcase model interpretability,
highlighting which parts of the sequence are most relevant for a predicted
label. The original datasets are available at http://bliulab.net/iDRBP\_MMC and
the codes are available at https://github.com/NimishaGhosh/LAMP-PRo.

</details>


### [9] [De novo peptide sequencing rescoring and FDR estimation with Winnow](https://arxiv.org/abs/2509.24952)
*Amandla Mabona,Jemma Daniel,Henrik Servais Janssen Knudsen,Rachel Catzel,Kevin Michael Eloff,Erwin M. Schoof,Nicolas Lopez Carranza,Timothy P. Jenkins,Jeroen Van Goey,Konstantinos Kalogeropoulos*

Main category: q-bio.QM

TL;DR: Winnow是一个模型无关的框架，用于从校准的de novo测序输出中估计假发现率，解决了现有工具缺乏原则性FDR估计方法的问题。


<details>
  <summary>Details</summary>
Motivation: 现有的de novo测序工具缺乏原则性的假发现率估计方法，依赖模型特定的置信度分数，这些分数通常校准不当，限制了结果的可信度、跨模型比较和验证成功率。

Method: Winnow使用神经网络将原始模型分数映射到校准置信度，基于肽谱匹配特征进行训练，并采用新颖的无诱饵FDR估计器计算PSM特定误差指标和实验范围的FDR估计。

Result: 应用于InstaNovo预测时，Winnow的校准器在固定FDR阈值下提高了召回率，其FDR估计器在参考蛋白质组和数据库搜索基准测试中能准确跟踪真实误差率。

Conclusion: Winnow确保了跨数据集的准确FDR控制，有助于释放de novo测序的全部潜力。

Abstract: Machine learning has markedly advanced de novo peptide sequencing (DNS) for
mass spectrometry-based proteomics. DNS tools offer a reliable way to identify
peptides without relying on reference databases, extending proteomic analysis
and unlocking applications into less-charted regions of the proteome. However,
they still face a key limitation. DNS tools lack principled methods for
estimating false discovery rates (FDR) and instead rely on model-specific
confidence scores that are often miscalibrated. This limits trust in results,
hinders cross-model comparisons and reduces validation success. Here we present
Winnow, a model-agnostic framework for estimating FDR from calibrated DNS
outputs. Winnow maps raw model scores to calibrated confidences using a neural
network trained on peptide-spectrum match (PSM)-derived features. From these
calibrated scores, Winnow computes PSM-specific error metrics and an
experiment-wide FDR estimate using a novel decoy-free FDR estimator. It
supports both zero-shot and dataset-specific calibration, enabling flexible
application via direct inference, fine-tuning, or training a custom model. We
demonstrate that, when applied to InstaNovo predictions, Winnow's calibrator
improves recall at fixed FDR thresholds, and its FDR estimator tracks true
error rates when benchmarked against reference proteomes and database search.
Winnow ensures accurate FDR control across datasets, helping unlock the full
potential of DNS.

</details>


<div id='q-bio.MN'></div>

# q-bio.MN [[Back]](#toc)

### [10] [Bifurcations and multistability in inducible three-gene toggle switch networks](https://arxiv.org/abs/2509.24926)
*Rebecca J. Rousseau,Rob Phillips*

Main category: q-bio.MN

TL;DR: 本文研究了效应分子在调控三基因网络多稳态动态中的作用，通过扩展标准双稳态开关模型，探索了效应分子浓度如何影响多稳态动态和分岔行为。


<details>
  <summary>Details</summary>
Motivation: 现有理论模型通常随意调整参数而不考虑生物控制机制，本文旨在研究效应分子（普遍存在于生物调控过程中）如何通过改变活性转录因子浓度来调控基因网络动态。

Method: 在标准双稳态开关基础上扩展到三基因网络，考虑变构调控机制，分析效应分子浓度对多稳态动态的影响，研究不同调控机制解释下的动态相空间分岔。

Result: 发现效应分子控制双功能蛋白的生物机制不仅改变了动态调控的表型趋势，还改变了可用的动态机制集合，确定了驱动表型决策的关键参数和调控特征。

Conclusion: 提供了一个实验可调控的结构，用于编码由单功能和双功能变构转录因子产生的可诱导多稳态行为，揭示了效应分子在调控复杂基因网络动态中的关键作用。

Abstract: Control of transcription presides over a vast array of biological processes
including through gene regulatory circuits that exhibit multistability. Two-
and three-gene network motifs are often found to be critical parts of the
repertoire of metabolic and developmental pathways. Theoretical models of these
circuits, however, typically vary parameters such as dissociation constants,
transcription rates, and degradation rates without specifying precisely how
these parameters are controlled biologically. In this paper, we examine the
role of effector molecules, which can alter the concentrations of the active
transcription factors that control regulation, and are ubiquitous to regulatory
processes across biological settings. We specifically consider allosteric
regulation in the context of extending the standard bistable switch to
three-gene networks, and explore the rich multistable dynamics exhibited in
these architectures as a function of effector concentrations. We then study how
the conditions required for tristability and more complex dynamics, and the
bifurcations in dynamic phase space upon tuning effector concentrations, evolve
under various interpretations of regulatory circuit mechanics, the underlying
activity of inducers, and perturbations thereof. Notably, the biological
mechanism by which we model effector control over dual-function proteins
transforms not only the phenotypic trend of dynamic tuning but also the set of
available dynamic regimes. In this way, we determine key parameters and
regulatory features that drive phenotypic decisions, and offer an
experimentally tunable structure for encoding inducible multistable behavior
arising from both single and dual-function allosteric transcription factors.

</details>


<div id='cs.LG'></div>

# cs.LG [[Back]](#toc)

### [11] [Fusing Sequence Motifs and Pan-Genomic Features: Antimicrobial Resistance Prediction using an Explainable Lightweight 1D CNN-XGBoost Ensemble](https://arxiv.org/abs/2509.23552)
*Md. Saiful Bari Siddiqui,Nowshin Tarannum*

Main category: cs.LG

TL;DR: 提出AMR-EnsembleNet集成框架，结合序列感知的1D CNN和特征学习的XGBoost模型，用于抗生素耐药性预测，在E. coli数据集上取得优异性能。


<details>
  <summary>Details</summary>
Motivation: 解决当前基因组序列分析方法忽略SNP顺序上下文，以及Transformer等模型在中等规模数据集上计算成本过高的问题。

Method: 开发轻量级1D CNN从SNP数据中学习序列模式，与XGBoost模型集成，结合序列特征和特征交互学习。

Result: 在809株E. coli菌株数据集上，对4种抗生素的耐药性预测表现优异，CIP的MCC达0.926，GEN的Macro F1-score达0.691。

Conclusion: 融合序列感知CNN和特征学习XGBoost的集成方法克服了单独使用无序特征或序列模型的局限性，能有效学习耐药性遗传信号。

Abstract: Antimicrobial Resistance (AMR) is a rapidly escalating global health crisis.
While genomic sequencing enables rapid prediction of resistance phenotypes,
current computational methods have limitations. Standard machine learning
models treat the genome as an unordered collection of features, ignoring the
sequential context of Single Nucleotide Polymorphisms (SNPs). State-of-the-art
sequence models like Transformers are often too data-hungry and computationally
expensive for the moderately-sized datasets that are typical in this domain. To
address these challenges, we propose AMR-EnsembleNet, an ensemble framework
that synergistically combines sequence-based and feature-based learning. We
developed a lightweight, custom 1D Convolutional Neural Network (CNN) to
efficiently learn predictive sequence motifs from high-dimensional SNP data.
This sequence-aware model was ensembled with an XGBoost model, a powerful
gradient boosting system adept at capturing complex, non-local feature
interactions. We trained and evaluated our framework on a benchmark dataset of
809 E. coli strains, predicting resistance across four antibiotics with varying
class imbalance. Our 1D CNN-XGBoost ensemble consistently achieved top-tier
performance across all the antibiotics, reaching a Matthews Correlation
Coefficient (MCC) of 0.926 for Ciprofloxacin (CIP) and the highest Macro
F1-score of 0.691 for the challenging Gentamicin (GEN) AMR prediction. We also
show that our model consistently focuses on SNPs within well-known AMR genes
like fusA and parC, confirming it learns the correct genetic signals for
resistance. Our work demonstrates that fusing a sequence-aware 1D CNN with a
feature-based XGBoost model creates a powerful ensemble, overcoming the
limitations of using either an order-agnostic or a standalone sequence model.

</details>


### [12] [Efficient Identification of High Similarity Clusters in Polygon Datasets](https://arxiv.org/abs/2509.23942)
*John N. Daras*

Main category: cs.LG

TL;DR: 提出一个通过减少需要验证的聚类数量来降低计算负载的框架，结合动态相似度索引阈值、监督调度和召回约束优化，在大规模地理空间分析中实现计算成本显著降低而不牺牲准确性。


<details>
  <summary>Details</summary>
Motivation: 虽然Shapely 2.0和Triton等工具能提高空间相似性计算效率，但在处理极大数据集时仍面临计算量过大的挑战。

Method: 集成动态相似度索引阈值、监督调度和召回约束优化的框架，利用核密度估计动态确定相似度阈值，机器学习模型优先处理聚类。

Result: 实验结果表明该方法具有可扩展性和有效性，在大规模地理空间分析中实现了计算成本的显著降低。

Conclusion: 该框架为大规模地理空间分析提供了一个实用的解决方案，能在不牺牲准确性的前提下显著降低计算负载。

Abstract: Advancements in tools like Shapely 2.0 and Triton can significantly improve
the efficiency of spatial similarity computations by enabling faster and more
scalable geometric operations. However, for extremely large datasets, these
optimizations may face challenges due to the sheer volume of computations
required. To address this, we propose a framework that reduces the number of
clusters requiring verification, thereby decreasing the computational load on
these systems. The framework integrates dynamic similarity index thresholding,
supervised scheduling, and recall-constrained optimization to efficiently
identify clusters with the highest spatial similarity while meeting
user-defined precision and recall requirements. By leveraging Kernel Density
Estimation (KDE) to dynamically determine similarity thresholds and machine
learning models to prioritize clusters, our approach achieves substantial
reductions in computational cost without sacrificing accuracy. Experimental
results demonstrate the scalability and effectiveness of the method, offering a
practical solution for large-scale geospatial analysis.

</details>


### [13] [Is Sequence Information All You Need for Bayesian Optimization of Antibodies?](https://arxiv.org/abs/2509.24933)
*Sebastian W. Ober,Calvin McCarter,Aniruddh Raghu,Yucen Lily Li,Alan N. Amin,Andrew Gordon Wilson,Hunter Elliott*

Main category: cs.LG

TL;DR: 本研究探索了在抗体贝叶斯优化中融入结构信息的不同方法，并与仅使用序列的方法进行比较，发现结构信息在早期优化阶段对稳定性有数据效率优势，但结合蛋白质语言模型软约束后，序列方法可以达到与结构方法相当的性能。


<details>
  <summary>Details</summary>
Motivation: 抗体治疗特性工程通常迭代且昂贵，贝叶斯优化是自然选择。但为高度结构化的抗体空间选择最优代理模型很困难，且可能因优化特性而异。此前没有研究尝试将结构信息融入抗体贝叶斯优化。

Method: 探索了将结构信息融入贝叶斯优化的不同方法，与多种仅序列方法进行比较，测试了两个抗体特性（结合亲和力和稳定性）。提出了基于蛋白质语言模型的"软约束"来引导优化到有前景的空间区域。

Result: 某些类型的结构信息在早期优化轮次中对稳定性提高了数据效率，但峰值性能相当。当结合蛋白质语言模型软约束时，亲和力的数据效率差距缩小，稳定性的差距消除，序列方法性能与基于结构的方法匹配。

Conclusion: 研究结果对贝叶斯优化中结构信息的必要性提出了质疑，表明在适当约束下，仅序列方法可以达到与结构方法相当的性能。

Abstract: Bayesian optimization is a natural candidate for the engineering of antibody
therapeutic properties, which is often iterative and expensive. However,
finding the optimal choice of surrogate model for optimization over the highly
structured antibody space is difficult, and may differ depending on the
property being optimized. Moreover, to the best of our knowledge, no prior
works have attempted to incorporate structural information into antibody
Bayesian optimization. In this work, we explore different approaches to
incorporating structural information into Bayesian optimization, and compare
them to a variety of sequence-only approaches on two different antibody
properties, binding affinity and stability. In addition, we propose the use of
a protein language model-based ``soft constraint,'' which helps guide the
optimization to promising regions of the space. We find that certain types of
structural information improve data efficiency in early optimization rounds for
stability, but have equivalent peak performance. Moreover, when incorporating
the protein language model soft constraint we find that the data efficiency gap
is diminished for affinity and eliminated for stability, resulting in
sequence-only methods that match the performance of structure-based methods,
raising questions about the necessity of structure in Bayesian optimization for
antibodies.

</details>


<div id='cs.DC'></div>

# cs.DC [[Back]](#toc)

### [14] [TeraAgent: A Distributed Agent-Based Simulation Engine for Simulating Half a Trillion Agents](https://arxiv.org/abs/2509.24063)
*Lukas Breitwieser,Ahmad Hesam,Abdullah Giray Yağlıkçı,Mohammad Sadrosadati,Fons Rademakers,Onur Mutlu*

Main category: cs.DC

TL;DR: TeraAgent是一个分布式代理仿真引擎，通过定制序列化机制和增量编码解决了跨服务器代理信息交换的性能瓶颈，实现了半万亿代理的极端规模仿真。


<details>
  <summary>Details</summary>
Motivation: 现有的BioDynaMo平台由于基于共享内存实现，无法跨服务器扩展，限制了大规模复杂系统仿真的能力。

Method: 提出了两种解决方案：1）定制序列化机制，允许从接收缓冲区直接访问和修改代理；2）利用代理仿真的迭代特性，通过增量编码减少数据传输。

Result: 实现了半万亿代理的仿真（84倍改进），通过增加计算节点减少结果时间，提高与第三方工具的互操作性，提供更多硬件灵活性。

Conclusion: TeraAgent成功解决了分布式代理仿真的关键性能瓶颈，为极端规模复杂系统仿真提供了可行方案。

Abstract: Agent-based simulation is an indispensable paradigm for studying complex
systems. These systems can comprise billions of agents, requiring the computing
resources of multiple servers to simulate. Unfortunately, the state-of-the-art
platform, BioDynaMo, does not scale out across servers due to its
shared-memory-based implementation.
  To overcome this key limitation, we introduce TeraAgent, a distributed
agent-based simulation engine. A critical challenge in distributed execution is
the exchange of agent information across servers, which we identify as a major
performance bottleneck. We propose two solutions: 1) a tailored serialization
mechanism that allows agents to be accessed and mutated directly from the
receive buffer, and 2) leveraging the iterative nature of agent-based
simulations to reduce data transfer with delta encoding.
  Built on our solutions, TeraAgent enables extreme-scale simulations with half
a trillion agents (an 84x improvement), reduces time-to-result with additional
compute nodes, improves interoperability with third-party tools, and provides
users with more hardware flexibility.

</details>


<div id='stat.ML'></div>

# stat.ML [[Back]](#toc)

### [15] [Identifying Memory Effects in Epidemics via a Fractional SEIRD Model and Physics-Informed Neural Networks](https://arxiv.org/abs/2509.22760)
*Achraf Zinihi*

Main category: stat.ML

TL;DR: 提出了基于物理信息神经网络(PINN)的分数阶SEIRD流行病模型参数估计框架，能够同时重建疫情轨迹并推断流行病学参数和分数记忆阶数α。


<details>
  <summary>Details</summary>
Motivation: 扩展经典整数阶模型以捕捉疾病进展、潜伏和恢复过程中的长程记忆效应，为预测、控制策略和非马尔可夫流行病过程分析提供工具。

Method: 通过L1离散化方案将Caputo分数阶导数嵌入网络残差，使用包含数据失配、物理残差和初始条件的复合损失函数，同时学习分数记忆阶数α和流行病学参数。

Result: 在合成Mpox数据上可靠恢复α和参数，在COVID-19应用中显示最优α∈(0,1]能捕捉记忆效应并提高预测性能。

Conclusion: 建立了PINN作为学习流行病动态中记忆效应的稳健工具，对预测、控制策略和非马尔可夫流行病过程分析具有重要意义。

Abstract: We develop a physics-informed neural network (PINN) framework for parameter
estimation in fractional-order SEIRD epidemic models. By embedding the Caputo
fractional derivative into the network residuals via the L1 discretization
scheme, our method simultaneously reconstructs epidemic trajectories and infers
both epidemiological parameters and the fractional memory order $\alpha$. The
fractional formulation extends classical integer-order models by capturing
long-range memory effects in disease progression, incubation, and recovery. Our
framework learns the fractional memory order $\alpha$ as a trainable parameter
while simultaneously estimating the epidemiological rates $(\beta, \sigma,
\gamma, \mu)$. A composite loss combining data misfit, physics residuals, and
initial conditions, with constraints on positivity and population conservation,
ensures both accuracy and biological consistency. Tests on synthetic Mpox data
confirm reliable recovery of $\alpha$ and parameters under noise, while
applications to COVID-19 show that optimal $\alpha \in (0, 1]$ captures memory
effects and improves predictive performance over the classical SEIRD model.
This work establishes PINNs as a robust tool for learning memory effects in
epidemic dynamics, with implications for forecasting, control strategies, and
the analysis of non-Markovian epidemic processes.

</details>
